FDA Inspection
Strides Pharma Science LimitedStrides Pharma Science Limited – FDA Inspection, Feb 5, 2019
Record Details
This FDA Inspection record concerns Strides Pharma Science Limited, with an inspection on February 5, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · edce7bdc-7d3b-4fdf-8ba1-d4b5331f68a9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1078143
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.180(b)Record maintenance 1 year (except exempt OTC)
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.194(a)(8)Second person sign off
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.42(b)Adequate space lacking to prevent mix-ups and contamination
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Strides Pharma Science Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 24, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Strides Pharma Science Limited
- FDA Inspection 1198198 - 2023-02-24
- FDA Inspection 1015484 - 2017-04-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.